VICL Vical Incorporated

1.05
+0.05  (+5%)
Previous Close 1
Open 1
Price To Book 0.44
Market Cap 22904661
Shares 21,816,041
Volume 654,009
Short Ratio
Av. Daily Volume 308,332

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data released September 19, 2016 did not meet primary endpoint.
ASP0113 Vaccine
Kidney transplant recipients
Phase 2 trial did not meet primary endpoint - June 11, 2018.
VCL-HB01 HSV-2 Therapeutic Vaccine
Genital Herpes in Adults
Data did not meet primary endpoint
Vaxfectin-formulated therapeutic vaccine
Herpes
Phase 3 data released January 22, 2018 - endpoints not met.
ASP0113 Vaccine
Hematopoietic cell transplant recipients